Continued vorapaxar versus withdrawed clopidogrel both on top of low dose aspirin in patients undergoing heart surgery: A call for randomized trial.

[1]  Sunil V. Rao,et al.  Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  C. Held,et al.  Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery , 2015, Journal of the American Heart Association.

[3]  R. Khouzam,et al.  Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome. , 2015, The American journal of cardiology.

[4]  M. Movahed,et al.  A Novel Inhibitor of Protease-activated Receptor 1: A Review of Chemical Structure and Mode of Action. , 2015, Reviews in cardiovascular medicine.

[5]  F. Eckstein,et al.  Prasugrel Increases the Need for Platelet Transfusions and Surgical Reexploration Rates Compared with Clopidogrel in Coronary Artery Bypass Surgery , 2014, Thoracic and Cardiovascular Surgeon.

[6]  K. Filion,et al.  Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials. , 2014, JACC. Cardiovascular interventions.

[7]  C. Held,et al.  Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). , 2014, Journal of the American College of Cardiology.

[8]  M. Akay,et al.  Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. , 2014, JAMA internal medicine.

[9]  D. Steinbrüchel,et al.  Off-Pump Versus On-Pump Coronary Artery Bypass Grafting , 2014, Current Cardiology Reports.

[10]  Xiaochun Ma,et al.  Safety and Efficacy Outcomes of Preoperative Aspirin in Patients Undergoing Coronary Artery Bypass Grafting , 2014, Journal of cardiovascular pharmacology and therapeutics.

[11]  V. Fuster,et al.  Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. , 2013, The lancet. Diabetes & endocrinology.

[12]  C. Held,et al.  Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial. , 2013, American heart journal.

[13]  P. Erwin,et al.  Dual Anti‐platelet Therapy After Coronary Artery Bypass Grafting: Is There Any Benefit? A Systematic Review and Meta‐Analysis , 2013, Journal of cardiac surgery.

[14]  Adil A M Al-Lawati,et al.  Continuing Aspirin Causes Higher Drainage Even under Full Protection with Antifibrinolytics , 2013, Thoracic and Cardiovascular Surgeon.

[15]  Howard K. Song,et al.  2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. , 2012, The Annals of thoracic surgery.

[16]  Marc P. Bonaca,et al.  Vorapaxar in the secondary prevention of atherothrombotic events. , 2012, The New England journal of medicine.

[17]  D. Steinbrüchel,et al.  Hypercoagulability in patients undergoing coronary artery bypass grafting: prevalence, patient characteristics and postoperative outcome. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  Giuseppe Ambrosio,et al.  Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. , 2012, The New England journal of medicine.

[19]  T. Athanasiou,et al.  Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. , 2011, European heart journal.

[20]  Michael A. Burke,et al.  Early clopidogrel use in non-ST elevation acute coronary syndrome and subsequent coronary artery bypass grafting. , 2011, American heart journal.

[21]  W. Saggau,et al.  Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests. , 2011, The Thoracic and cardiovascular surgeon.

[22]  J. Segal,et al.  Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. , 2011, Journal of the American College of Cardiology.

[23]  R. Körfer,et al.  Prevalent platelet dysfunction in patients with aortic valve disease. , 2008, The Journal of heart valve disease.